Surveillance for Rare Infectious Diseases: Is one passive data source enough for Haemophilus influenzae?

European Journal of Public Health

Volumn 18, Issue 4, 2008, Pages 371-375

  Milde Busch, Astrid ^a,d   Kalies, Helen ^a   Rückinger, Simon ^a   Siedler, Anette ^b   Rosenbauer, Joachim ^c   Von Kries, Rüdiger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Psychophysiol/Neurophysiol Dept   (Germany)

Author keywords

Completeness; Haemophilus influenzae; Hib; Passive surveillance system

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HOSPITAL INFORMATION SYSTEM; HUMAN; INFANT; INFORMATION PROCESSING; MEDICAL RECORD; MORBIDITY; NEWBORN; PRIORITY JOURNAL; RARE DISEASE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; GERMANY; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; INFANT; INFANT, NEWBORN; MALE; SENTINEL SURVEILLANCE;

EID: 48149097061     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckn023     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Ten great public health achievements - United States, 1900-1999. MMWR 1999;48:241-3.
2. Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children - United States, 1900-1998. MMWR 1999;48:243-8.
3. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
4. Garpenholt O, Silferdal SA, Hugossen S, et al. The impact of Haemophilus influenzae type b vaccination in Sweden. Scand J Infect Dis 1996;28:165-9.
5. Hargreaves RM, Slack MP, Howard AJ, et al. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. Br Med J 1996;312:160-1.
6. Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 1997;21:173-6.
7. von Kries R, Heinrich B, Böhm O, et al. Systemische Haemophilus influenzae Erkrankungen in Deutschland. [Incidence of Haemophilus influenzae infections in Germany between 1992 and 1995.]. Monatsschr Kinderheilkd 1997;145:136-43.
8. Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002;86:396-9.
9. Ramsay ME, McVernon J, Andrews NJ, et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. JID 2003;188:481-5.
10. Garner D, Weston V. Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 2003;361:360-1.
11. McVernon J, Trotter CL, Slack MPE, Ramsay ME. Trend in Haemophilus influenzae type b infections in adults in England and Wales: Surveillance study. Br Med J 2004;329:655-8.
12. Rijker GT, Vermeer-de Bondt PE, Spanjaard L, et al. Return of Haemophilus influenzae type b infections. Lancet 2003;361:1563-4.
13. Spanjaard L, van den Hof S, de Melker HE, et al. Increase in the number of invasive Haemophilus influenzae type b infections. Nederlands Tijdschrift voor Geneeskunde 2005;149:2738-42.
14. Kalies H, Verstraeten T, Grote V, et al. Four and one-half-year follow-up of the effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/ Haemophilus influenzae type b and Diphtheria-Tetanus Toxoids-Acellular Pertussis-Inactivated Poliovirus/H. influenzae type b combination vaccines in Germany. Pediatr Infect Dis J 2004;23:944-50.
15. Act on the Prevention and Control of Infectious Diseases in man (Protection against Infection Act): http://bundesrecht.juris.de/ifsg/index.html (accessed 16 January 2008).
16. Zucs AP, Benzler J, Krause G. Mandatory disease reporting by German laboratories: a survey of attitudes practices and needs. Euro Surveill 2005;10:26-7.
17. Faensen D, Claus H, Benzler J, et al. SurvNet@RKI - A multistate electronic reporting system for communicable diseases. Euro Surveill 2006;11:100-3.
18. von Kries R, Heinrich B, Hermann M. Pädiatrische Epidemiologie in Deutschland: Forschungsinstrument ESPED (Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland). [German paediatric surveillance unit (ESPED).] Monatsschr Kinderheilkd 2001;149:1191-7.
19. Cormack RM. Problems with using capture-recapture in epidemiology: an example of a measles epidemic. J Clin Epidemiol 1999;52:909-14.
20. Bishop YMM, Fienberg SE, Holland PW. Discrete Multivariate Analysis: Theory and Practice. Cambridge: The MIT Press, 1975.
21. Hook EB, Regal RR. Capture-recapture methods in epidemiology: Methods and limitations. Epidemiol Rev 1995;17:243-64.
22. European Union Invasive Bacterial Infections Surveillance Network. Invasive Haemophilus influenzae in Europe 2003/2004: http://www.euibis. org/documents/20032004_hib.pdf (accessed 30 October 2007).
23. European Union Invasive Bacterial Infections Surveillance Network. An evaluation of Haemophilus influenzae type b (Hib) vaccination and description of risk factors for Hib vaccine failure in Europe 1996-1998: http://www.euibis.org/documents/hib_vaccine_evaluation.pdf (accessed 30 October 2007).
24. Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytic literature review. Am J Epidemiol 2002;155:866-74.
25. Hedicke J, Schnoor M, Schübel N, et al. Ergebnisvergleich: aktives versus passives Meldesystem bei Fällen mit ambulant erworbener Pneumonie. Ergebnisse aus dem Kompetenznetzwerk CAPNETZ. [Results of a comparison: Active versus passive reporting in cases of community acquired pneumonia. Results of the German Competence Network CAPNETZ.] Gesundheitswesen 2006;68:638-42.